Sunshine Biopharma Inc
sunshinebiopharma.comWhat Do They Do?
Sells generic prescription medicines to Canadian pharmacies and wholesalers and OTC supplements through Amazon; researches cancer and coronavirus drug candidates.
10-K for FY2025, filed Apr 3, 2026We are a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology…View ↗
In addition, we are conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA, an LNP encapsulated mRNA…View ↗
In-licensing and Supply Agreements: Nora Pharma acquires the rights to import, market, sell and distribute the products in Canada by…View ↗
Our generic drugs are currently being sold in Canada in the province of Quebec, and to a much lesser extent in the provinces of Ontario…View ↗
Over 97% of the Company’s revenues are derived from the sale of pharmaceutical products. Pharmaceutical products can only be sold to a…View ↗
How Do They Make Money?
Pharmacies and wholesalers pay for pharmaceutical products when they receive them; the company invoices at that point, with payment due afterward under the stated terms.
10-K for FY2025, filed Apr 3, 2026
$36.3M
-
10-K for FY2025, filed Apr 3, 2026
$36.3M ↗
Who Are Their Customers?
Pharmacies buy directly through Nora Pharma’s sales representatives, while wholesalers handle indirect sales under contracts; OTC supplements are sold on Amazon in Canada.
10-K for FY2025, filed Apr 3, 2026
Do Revenues Turn Into Profits?
No. It lost $6M in FY2025.
10-K for FY2025, filed Apr 3, 2026
−$6.2MView ↗
10-K for FY2025, filed Apr 3, 2026
−$6MView ↗
10-K for FY2025, filed Apr 3, 2026
−$5.5MView ↗
How Are They Changing?
Growing. Revenue grew 158.9x in 4 years, from $228.4K in FY2021 to $36.3M in FY2025, about 255% a year.
OTC sales geography
The older report described OTC products sold in Canada and partly in the United States; the latest says it stopped U.S. Amazon sales, with OTC sales remaining in Canada.
10-K for FY2022, filed Apr 4, 2023 10-K for FY2025, filed Apr 3, 2026In addition, we have the following nonprescription OTC products on the market in Canada and partially in the U.S.:View ↗
Our generic drugs are currently being sold in Canada in the province of Quebec, and to a much lesser extent in the provinces of Ontario…View ↗
Who Do They Compete With?
Competes with Pfizer, Merck, Gilead, Eli Lilly, Regeneron, Moderna, Amgen, Roche, Bristol-Myers Squibb, and Novartis
10-K for FY2025, filed Apr 3, 2026Our Anti-Coronavirus drug development project is in direct competition with several companies in the U.S. that have developed effective…View ↗
Loading...
